Characterization of ampicillin-resistant Haemophilus parainfluenzae.

Antimicrobial Agents and Chemotherapy
D W ScheifeleM C Roberts

Abstract

Carriage of ampicillin-resistant (Ampr) Haemophilus parainfluenzae has become frequent among children in our community, although carriage of Ampr Haemophilus influenzae remains uncommon. In this study we characterized the mechanism of ampicillin resistance in 27 representative isolates of H. parainfluenzae. As determined by isoelectric focusing, each isolate had a TEM-1 beta-lactamase; substrate profiles assessed for enzymes from 10 strains were also consistent with TEM-1 enzyme. Agarose gel electrophoresis revealed a plasmid of 23 to 34 megadaltons in each isolate and a small plasmid (less than or equal to 4 megadaltons) in 14 isolates. Transfer of ampicillin resistance to H. influenzae Rd was achieved during membrane mating with 14 of 15 donors. The transconjugants exhibited high-level ampicillin resistance (greater than or equal to 50 micrograms/ml), which was stable despite serial passage of isolates on antibiotic-free media. The transconjugants tested retained fertility. Cryptic plasmids were discovered in 7 of 25 antibiotic-susceptible H. parainfluenzae isolates. Our data suggest that H. parainfluenzae may play an important role in the exchange of Ampr genes among throat bacteria.

References

Jul 1, 1977·Journal of Bacteriology·L P ElwellS Falkow
Jun 1, 1978·The Journal of Pediatrics·V SyriopoulouV Howie
May 1, 1978·Antimicrobial Agents and Chemotherapy·N K Harkess, M L Murray
Aug 1, 1979·Journal of Bacteriology·J H Stuy
Feb 1, 1977·Journal of Clinical Microbiology·M E Lund, D J Blazevic
May 1, 1977·Antimicrobial Agents and Chemotherapy·J B Mayo, L R McCarthy
Feb 1, 1978·Antimicrobial Agents and Chemotherapy·W V ShawF W Goldstein
Jun 1, 1976·The Journal of Antimicrobial Chemotherapy·R B Sykes, M Matthew
Apr 1, 1975·The Journal of Pediatrics·B B EmersonD H Smith
Aug 1, 1975·Infection and Immunity·L P ElwellS Falkow
Apr 1, 1975·Journal of Bacteriology·F HeffronS Falkow
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Jan 1, 1974·Molecular & General Genetics : MGG·R W Hedges, A E Jacob
Feb 1, 1972·Antimicrobial Agents and Chemotherapy·R B Sykes, K Nordström
Apr 1, 1970·Journal of General Microbiology·G W Jack, M H Richmond
Feb 1, 1981·Journal of Bacteriology·M E Kahn, R Gromkova
Aug 1, 1981·Journal of Bacteriology·R LaufsP M Kaulfers
Mar 1, 1981·The Journal of Infectious Diseases·D W Scheifele, S J Fussell
Oct 1, 1980·Journal of Bacteriology·M C Roberts, A L Smith
Oct 1, 1980·Antimicrobial Agents and Chemotherapy·M C RobertsA L Smith
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·I N SimpsonC H O'Callaghan
Sep 1, 1980·The Journal of Antimicrobial Chemotherapy·E M Ndawula, P J Sanderson
Feb 1, 1981·Journal of Medical Microbiology·G G Palmer
May 1, 1962·The Biochemical Journal·R P NOVICK

❮ Previous
Next ❯

Citations

Oct 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L GutmannJ F Acar
Oct 1, 1986·European Journal of Clinical Microbiology·I EliassonK Prellner
Jun 1, 1983·European Journal of Clinical Microbiology·D W Scheifele, S J Fussell
Mar 15, 2005·International Journal of Pediatric Otorhinolaryngology·Satoru KaiedaHaruo Takahashi
May 9, 1998·International Journal of Antimicrobial Agents·M C Roberts
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Ioanna D DimopoulouDerrick W Crook
Apr 13, 2007·Clinical Microbiology Reviews·Stephen TristramPeter C Appelbaum
Aug 16, 2016·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Conar R O'NeilBayan Missaghi
Nov 24, 1998·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·M C Roberts
Jul 1, 1987·The Annals of Otology, Rhinology, and Laryngology·J P Dudley
May 16, 2002·Periodontology 2000·Marilyn C Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.